HEMISPHERX BIOPHARMA INC 4/A
4/A · HEMISPHERX BIOPHARMA INC · Filed Jun 29, 2017
Insider Transaction Report
Form 4/AAmended
Pascale Adam
Chief Accounting Officer
Transactions
- Award
Options to buy Common Stock
2017-06-15$0.44/sh+4,738$2,085→ 4,738 totalExercise: $0.49From: 2017-06-15Exp: 2027-06-15→ Common Stock (4,738 underlying)
Footnotes (1)
- [F1]Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017.